Identification of a blood-based biomarker panel for classification of Alzheimer's disease

International Journal of Neuropsychopharmacology

Volumn 14, Issue 9, 2011, Pages 1147-1155

  Laske, Christoph ^a   Leyhe, Thomas ^a,b   Stransky, Elke ^a   Hoffmann, Nadine ^a   Fallgatter, Andreas J ^a   Dietzsch, Janko ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Alzheimer's disease; biomarker; blood; diagnostic test; support vector machine

Indexed keywords

ADIPONECTIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; ANGIOTENSIN I; ANGIOTENSIN II; BRAIN DERIVED NEUROTROPHIC FACTOR; COLONY STIMULATING FACTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN; LOW DENSITY LIPOPROTEIN; MACROPHAGE DERIVED CHEMOKINE; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR BB; RANTES; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VON WILLEBRAND FACTOR; AUTOANTIBODY; BIOLOGICAL MARKER; HYDROCORTISONE; OXIDIZED LOW DENSITY LIPOPROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CELL GROWTH; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; THROMBOGENICITY; BLOOD; COHORT ANALYSIS; DRUG ANTAGONISM; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; SUPPORT VECTOR MACHINE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AUTOANTIBODIES; BIOLOGICAL MARKERS; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROCORTISONE; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINES; VON WILLEBRAND FACTOR;

EID: 84856068336     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000459     Document Type: Article

References (36)

1. Akaza I, Yoshimoto T, Tsuchiya K, Hirata Y (2010). Endothelial dysfunction associated with hypercortisolism is reversible in cushing's syndrome. Endocrine Journal 57, 245-252.
2. Becker-Barroso E (2005). More support for vascular basis of Alzheimer's disease. Lancet Neurology 4, 598-599.
3. Bednarska-Makaruk M, Rodo M, Graban A, Lojkowska W, et al. (2009). Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients. Journal of the Neurological Sciences 283, 137-138.
4. Blennow K, Hampel H (2003). CSF markers for incipient Alzheimer's disease. Lancet Neurology 2, 605-613. (Pubitemid 37162569)
5. Brizzi P, Tonolo G, Bertrand G, Carusillo F, et al. (2004). Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status. Clinical Chemistry and Laboratory Medicine 42, 164-170. (Pubitemid 38401443)
6. Casonato A, Daidone V, Sartorello F, Albiger N, et al. (2008). Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor : the lesson learned from Cushing syndrome. British Journal of Haematology 140, 230-235. (Pubitemid 350265047)
7. Catto AJ, Grant PJ (1995). Risk factors for cerebrovascular disease and the role of coagulation and fibrinolysis. Blood Coagulation & Fibrinolysis 6, 497-510.
8. Csernansky JG, Dong H, Fagan AM, Wang L, et al. (2006). Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. American Journal of Psychiatry 163, 2164-2169. (Pubitemid 46114238)
9. De la Torre JC (2002). Alzheimer's disease as a vascular disorder : nosological evidence. Stroke 33, 1152-1162.
10. Folstein MF, Folstein SE, McHugh PR (1975). 'Mini-Mental-State'. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189-198.
11. Gomez Ravetti M, Moscato P (2008). Identification of a 5-protein biomarker molecular signature for predicting Alzheimer's disease. PLoS One 3, e3111.
12. Hastie T, Tibshirani R, Friedman J (2001). The Elements of Statistical Learning, (Springer Series in Statistics). New York: Springer.
13. Kankaanpää J, Turunen SP, Moilanen V, Hörkkö S, et al. (2009). Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease. Neurobiology of Disease 33, 467-472.
14. Laske C, Stellos K, Eschweiler GW, Leyhe T, et al. (2008a). Decreased CXCL12 (SDF-1) plasma levels in early Alzheimer's disease : a contribution to a deficient hematopoietic brain support? Journal of Alzheimer's Disease 15, 83-95.
15. Laske C, Stellos K, Stransky E, Leyhe T, et al. (2009a). Decreased plasma levels of granulocyte-colony stimulating factor (G-CSF) in patients with early Alzheimer's disease. Journal of Alzheimer's Disease 17, 115-123.
16. Laske C, Stellos K, Stransky E, Seizer P, et al. (2008b). Decreased plasma and cerebrospinal fluid levels of stem cell factor in patients with early Alzheimer's disease. Journal of Alzheimer's Disease 15, 451-460.
17. Laske C, Stransky E, Fritsche A, Eschweiler GW, et al. (2009b). Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia. European Archives of Psychiatry and Clinical Neurosciences 259, 80-85.
18. Laske C, Stransky E, Hoffmann N, Maetzler W, et al. (2010). Macrophage colony-stimulating factor (M-CSF) in plasma and CSF of patients with mild cognitive impairment and Alzheimer's disease. Current Alzheimer Research 7, 409-414.
19. Laske C, Stransky E, Leyhe T, Eschweiler GW, et al. (2007). BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. Journal of Psychiatric Research 41, 387-394. (Pubitemid 46187251)
20. Lee JA, Verleysen M (2007). Nonlinear Dimensionality Reduction (Information Science and Statistics Series). Berlin : Springer.
21. Magnin B, Mesrob L, Kinkingnéhun S, Pélégrini-Issac M, et al. (2009). Support vector machine-based classification of Alzheimer's disease from whole-brain anatomical MRI. Neuroradiology 51, 73-83.
22. Mari D, Parnetti L, Coppola R, Bottasso B, et al. (1996). Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease. Thrombosis & Haemostasis 75, 216-218. (Pubitemid 26081469)
23. Marksteiner J, Kemmler G, Weiss EM, Knaus G, et al. (2009). Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease. Neurobiology of Aging. Published online : 22 April 2009. doi:10.1016/j.neurobiolaging.2009.03.011.
24. McKhann G, Drachman D, Folstein M, Katzman R, et al. (1984). Clinical diagnosis of Alzheimer's disease : report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 30-34.
25. Querfurth HW, LaFerla FM (2010). Alzheimer's disease. New England Journal of Medicine 362, 329-344.
26. R Development Core Team (2009). R, A language and environment for statistical computing (http://www.R-project.org. R Foundation for Statistical Computing, Vienna, Austria.
27. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, et al. (2007). Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nature Medicine 13, 1359-1362. (Pubitemid 350073592)
28. Ryu JK, McLarnon JG (2009). A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. Journal of Cellular and Molecular Medicine 13, 2911-2925.
29. Sadler JE (1998). Biochemistry and genetics of von Willebrand factor. Annual Review of Biochemistry 67, 395-424. (Pubitemid 28411134)
30. Schrijvers EMC, Soares HD, Hofman A, Koudstaal PJ, et al. (2009). Prediction of Alzheimer's disease by means of a biomarker profile in the Rotterdam Study. Alzheimer's & Dementia 5 (Suppl. 1), 132.
31. Sing T, Sander O, Beerenwinkel N, Lengauer T (2005). ROCR: visualizing classifier performance in R. Bioinformatics 21, 3940-3941. (Pubitemid 41535515)
32. VapnikV(1998). Statistical Learning Theory. New York: Wiley.
33. Verleysen M, Damien F (2005). The curse of dimensionality in data mining and time series prediction, computational intelligence and bioinspired systems. Lecture Notes in Computer Science 3512, 758-770. (Pubitemid 41343046)
34. Witten I, Frank E (2005). Data Mining: Practical Machine Learning Tools and Techniques, 2nd edn. San Francisco: Morgan Kaufmann.
35. Zipser BD, Johanson CE, Gonzalez L, Berzin TM, et al. (2007). Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiology of Aging 28, 977-986. (Pubitemid 46635913)
36. Zlokovic BV (2005). Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends in Neurosciences 28, 202-208. (Pubitemid 40445527)